AMH
8
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
11 treatments under study, led by Chemiluminescence
Research Leaders
11 sponsors active, led by Hvidovre University Hospital
Related Conditions
Often studied with 19 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (8)
Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density
In Vitro Maturation of Human Eggs
Hormones in Hypogonadotropic Hypogonadism
AMHR2 Polymorphism in Blood and Granulosa Cells in Unexplained Infertility
Predictive Value of New AMH Test Method for Ovarian Response
AMH and Pregnancy Outcome in IVF
Serum AMH Levels in Patients Who Underwent Hypogastric Artery Ligation
Ovarian Function and Reserve Parameters After Discontinuation of Long-term Use of Oral Contraception
Research Network
Common Treatments
- Chemiluminescence1
- Pausing Oral Contraceptive1
- Elisa1
- Blood Sample1
- Hypogastric Artery Ligation1
Active Sponsors
- Hvidovre University Hospital1
- Herlev Hospital1
- Anders Nyboe Andersen1
- Al Baraka Fertility Hospital1
- Medical University of Vienna1
Top Investigators
Rigshospitalet, The Fertility Clinic
BEZMİALEM VAKIF ÜNİVERSİTESİ
Reproductive & Genetic Hospital of CITIC-Xiangya
Medical University of Vienna
Kanuni Sultan Suleyman Training and Research Hospital
Related Conditions
- Ivf2
- Infertility2
- Infertility Female2
- Diet Habit1
- Hypogonadism Hypogonadotropic1